Correlation Engine 2.0
Clear Search sequence regions

  • apixaban (7)
  • apoptosis (4)
  • breast cancer (1)
  • cell (16)
  • cell movement (1)
  • cells cultures (1)
  • colon cancer (1)
  • dermal (1)
  • drugs effect (1)
  • factor xa (2)
  • fibroblast (3)
  • gene (4)
  • humans (1)
  • lung (1)
  • necrosis (1)
  • ovarian cancer (1)
  • p16 (2)
  • prostate (1)
  • pyrazoles (2)
  • rt pcr (1)
  • vitro (4)
  • Sizes of these terms reflect their relevance to your search.

    Cancer is associated with hypercoagulability. However, several data suggest that anticoagulant drugs may have an effect on tumor development and progression mediated by both coagulation dependent processes and non-coagulation dependent processes. Therefore, we investigated the in vitro effects of Apixaban on cell proliferation, mortality, cell migration, gene expression and matrix metalloproteinase in 5 different cancer cell lines. The following cancer cell lines, and 2 normal fibroblast cultures (lung and dermal fibroblasts), were studied: OVCAR3 (ovarian cancer), MDA MB 231 (breast cancer), CaCO-2 (colon cancer), LNCaP (prostate cancer) and U937 (histiocytic lymphoma). Proliferation and cell mortality were assessed in control cells and Apixaban treated cultures (dose from 0.1 to 5 μg/ml, 0 to 96-h). Necrosis/Apoptosis (fluorescence microscopy), cell migration (24-h after scratch test), matrix metalloproteinase (MMP) activity and mRNA expression (RT PCR) of p16, p21, p53 and HAS were also assessed. High-dose (5 μg/ml) Apixaban incubation was associated with a significantly reduced proliferation in 3 cancer cell lines (OVCAR3, CaCO-2 and LNCaP) and with increased cancer cell mortality in all, except LNCaP, cancer lines. Apoptosis seems to account for the increased mortality. The migration capacity seems to be impaired after high-dose Apixaban incubation in OVCAR3 and CaCO-2 cells. Data on mRNA expression suggest a consistent increase in tumor suppression gene p16 in all cell lines. Our data suggest that high-dose Apixaban may be able to interfere with cancer cell in vitro, reducing proliferation and increasing cancer cell mortality through apoptosis in several cancer cell lines.


    Luigina Guasti, Alessandro Squizzato, Paola Moretto, Davide Vigetti, Walter Ageno, Francesco Dentali, Andrea M Maresca, Leonardo Campiotti, Anna M Grandi, Alberto Passi. In vitro effects of Apixaban on 5 different cancer cell lines. PloS one. 2017;12(10):e0185035

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 29023465

    View Full Text